GlassScriptPhysician profile
Robert S Williams
NPI 1851339709
$33,355.10
in general payments reported to CMS, 2019-2025
57 companies · $7,876 in 2025
The $7,876 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,321 · 2020: $1,044 · 2021: $2,614 · 2022: $1,749 · 2023: $2,095 · 2024: $17K · 2025: $7,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $22K · Food and Beverage: $4,108 · Education: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $22,071.43 |
| Food and Beverage | $4,108.44 |
| Education | $446.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Central Indiana Urs Consumables, LLC | $22,071.43 | 2024-2025 | Dornier Medtech, Cvac Aspiration System, Dornier Medtech |
| Axonics, INC. | $1,779.62 | 2020-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $1,703.68 | 2019-2025 | Xtandi, Veozah |
| Janssen Biotech, INC. | $761.51 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $647.94 | 2019-2025 | |
| Rochester Medical Corporation | $536.46 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $482.15 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $415.20 | 2019-2025 | Lupron Depot |
| C. R. Bard, INC. & Subsidiaries | $354.17 | 2023-2024 | Bard Urinary Drainage Bag |
| Antares Pharma, INC. | $348.97 | 2020-2023 | Nocdurna, Xyosted, Tlando |
| Pfizer INC. | $334.49 | 2019-2025 | |
| Neotract INC. | $325.62 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $300.62 | 2019-2024 | Provenge |
| Boston Scientific Corporation | $266.25 | 2019-2025 | Axonics |
| Coloplast Corp | $265.76 | 2019-2022 |
Show all 56 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$47,040.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.